# Sagimet Biosciences Inc.: Form 8-K, filed Apr 27, 2026

- Company: [Sagimet Biosciences Inc.](/companies/sgmt.md) (CIK 1400118)
- Form: 8-K
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 11:00 ET
- Period: 2026-04-27
- Accession: 0001104659-26-048971
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1400118/000110465926048971/tm2612738d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1400118/000110465926048971/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1400118/000110465926048971/tm2612738d2_8k.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-048971. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.